317 related articles for article (PubMed ID: 30190820)
1. Molecular pathology of cutaneous melanoma.
van Kempen LC; Redpath M; Robert C; Spatz A
Melanoma Manag; 2014 Nov; 1(2):151-164. PubMed ID: 30190820
[TBL] [Abstract][Full Text] [Related]
2. Association between tumor size and Breslow's thickness in malignant melanoma: a cross-sectional, multicenter study.
Moreno-Ramírez D; Ojeda-Vila T; Ríos-Martín JJ; Nieto-García A; Ferrándiz L
Melanoma Res; 2015 Oct; 25(5):450-2. PubMed ID: 26237766
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of sentinel lymph node biopsy in melanomas of different Breslow's thickness.
Seyed Jafari SM; Jäckle P; Michel A; Angermeier S; Hunger R; Shafighi M
Swiss Med Wkly; 2016; 146():w14358. PubMed ID: 27684508
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological Features and Prognostic Factors of Malignant Melanoma: A Retrospective Analysis of Thai Patients in Ramathibodi Hospital.
Ingkaninanda P; Visessiri Y; Rutnin S
J Med Assoc Thai; 2015 Aug; 98(8):820-7. PubMed ID: 26437541
[TBL] [Abstract][Full Text] [Related]
5. Observational study on the mitotic rate and other prognostic factors in cutaneous primary melanoma arising from naevi and from melanoma de novo.
Betti R; Santambrogio R; Cerri A; Vergani R; Moneghini L; Menni S
J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1738-41. PubMed ID: 24673663
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the Wide Spectrum of Melanoma Biomarkers.
Revythis A; Shah S; Kutka M; Moschetta M; Ozturk MA; Pappas-Gogos G; Ioannidou E; Sheriff M; Rassy E; Boussios S
Diagnostics (Basel); 2021 Jul; 11(8):. PubMed ID: 34441278
[TBL] [Abstract][Full Text] [Related]
7. Novel biomarkers in malignant melanoma.
Bosserhoff AK
Clin Chim Acta; 2006 May; 367(1-2):28-35. PubMed ID: 16480699
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of LKB1 promoter methylation in cutaneous malignant melanoma.
Zhang W; Li X; Song G; Luo D
Oncol Lett; 2017 Aug; 14(2):2075-2080. PubMed ID: 28781649
[TBL] [Abstract][Full Text] [Related]
9. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
[TBL] [Abstract][Full Text] [Related]
10. Sentinel node biopsy in cutaneous melanoma: correlations between melanoma prognostic factors and sentinel node status.
Minutilli E; Giannarelli D; Anzà M; Garinei R; Perri P; Botti C; Piarulli L; Bruno P; Rea S; Visca R; Mottolese M; Di Filippo S; Di Filippo F
J Exp Clin Cancer Res; 2007 Mar; 26(1):71-6. PubMed ID: 17550134
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.
Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F
Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434
[TBL] [Abstract][Full Text] [Related]
12. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures.
Wagner JD; Corbett L; Park HM; Davidson D; Coleman JJ; Havlik RJ; Hayes JT
Plast Reconstr Surg; 2000 May; 105(6):1956-66. PubMed ID: 10839392
[TBL] [Abstract][Full Text] [Related]
14. Prognostic index for clinical Stage I cutaneous malignant melanoma.
Hacene K; Le Doussal V; Brunet M; Lemoine F; Guerin P; Hebert H
Cancer Res; 1983 Jun; 43(6):2991-6. PubMed ID: 6850610
[TBL] [Abstract][Full Text] [Related]
15. PAS-positive loops and networks as a prognostic indicator in cutaneous malignant melanoma.
Thies A; Mangold U; Moll I; Schumacher U
J Pathol; 2001 Dec; 195(5):537-42. PubMed ID: 11745688
[TBL] [Abstract][Full Text] [Related]
16. Melanoma susceptibility as a complex trait: genetic variation controls all stages of tumor progression.
Ferguson B; Ram R; Handoko HY; Mukhopadhyay P; Muller HK; Soyer HP; Morahan G; Walker GJ
Oncogene; 2015 May; 34(22):2879-86. PubMed ID: 25088201
[TBL] [Abstract][Full Text] [Related]
17. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.
Blaheta HJ; Ellwanger U; Schittek B; Sotlar K; MacZey E; Breuninger H; Thelen MH; Bueltmann B; Rassner G; Garbe C
J Invest Dermatol; 2000 Apr; 114(4):637-42. PubMed ID: 10733666
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
19. Does high-frequency (40-60 MHz) ultrasound imaging play a role in the clinical management of cutaneous melanoma?
Semple JL; Gupta AK; From L; Harasiewicz KA; Sauder DN; Foster FS; Turnbull DH
Ann Plast Surg; 1995 Jun; 34(6):599-605; discussion 606. PubMed ID: 7661536
[TBL] [Abstract][Full Text] [Related]
20. Treatment Outcome and Prognostic Factors for Malignant Skin Melanoma Treated with Radical Surgery.
Majewski W; Stanienda K; Wicherska K; Ulczok R; Wydmanski J
Asian Pac J Cancer Prev; 2015; 16(14):5709-14. PubMed ID: 26320440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
